Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 12—December 2010
Research

Hantavirus Pulmonary Syndrome in Argentina, 1995–2008

Valeria P. MartinezComments to Author , Carla M. Bellomo, María Luisa Cacace, Paola Suárez, Liliana Bogni, and Paula J. Padula
Author affiliations: Author affiliations: Administración Nacional de Laboratorios e Institutos de Salud “Dr. C. G. Malbrán,” Buenos Aires, Argentina (V.P. Martinez, C.M. Bellomo, P.J. Padula); Hospital San Vicente de Paul de la Nueva Orán, Salta, Argentina (M.L. Cacace); Hospital Descentralizado–Región Sanitaria XI–Ministerio de Salud de la Provincia de Buenos Aires, Buenos Aires (P. Suarez); Área Programática Esquel–Secretaría de Salud de la Provincia de Chubut, Esquel, Argentina (L. Bogni)

Main Article

Figure 1

Distribution of hantavirus pulmonary syndrome (HPS) cases in Argentina, 1995–2008. A) The 5 Argentine epidemiologic regions and percentages of HPS cases in each one are shown. B) Six of the 18 ecoregions (18) represented by the colors indicated in the reference key; percentages of HPS cases in each ecoregion are shown. Location of HPS cases is represented approximately by point density. Total no. of cases analyzed: 692; confirmed cases of person-to-person transmission were excluded from this ana

Figure 1. Distribution of hantavirus pulmonary syndrome (HPS) cases in Argentina, 1995–2008. A) The 5 Argentine epidemiologic regions and percentages of HPS cases in each one are shown. B) Six of the 18 ecoregions (18) represented by the colors indicated in the reference key; percentages of HPS cases in each ecoregion are shown. Location of HPS cases is represented approximately by point density. Total no. of cases analyzed: 692; confirmed cases of person-to-person transmission were excluded from this analysis. NOA, Northwest; NEA, Northeast.

Main Article

References
  1. Nichol  ST, Spiropoulou  CF, Morzunov  S, Rollin  PE, Ksiazek  TG, Feldmann  H, Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science. 1993;262:914–7. DOIPubMedGoogle Scholar
  2. Khan  AS, Ksiazek  TG, Peters  CJ. Hantavirus pulmonary syndrome. Lancet. 1996;347:739–41. DOIPubMedGoogle Scholar
  3. Hjelle  B, Torrez-Martinez  N, Koster  FT. Hantavirus pulmonary syndrome–related virus from Bolivia. Lancet. 1996;347:57. DOIPubMedGoogle Scholar
  4. Lopez  N, Padula  P, Rossi  C, Lazaro  ME, Franze-Fernandez  MT. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology. 1996;220:223–6. DOIPubMedGoogle Scholar
  5. Toro  J, Vega  JD, Khan  AS, Mills  JN, Padula  P, Terry  W, An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg Infect Dis. 1998;4:687–94. DOIPubMedGoogle Scholar
  6. da Silva  MV, Vasconcelos  MJ, Hidalgo  NT, Veiga  AP, Canzian  M, Marotto  PC, Hantavirus pulmonary syndrome. Report of the first three cases in São Paulo, Brazil. Rev Inst Med Trop Sao Paulo. 1997;39:231–4.PubMedGoogle Scholar
  7. Johnson  AM, de Souza  LT, Ferreira  IB, Pereira  LE, Ksiazek  TG, Rollin  PE, Genetic investigation of novel hantaviruses causing fatal HPS in Brazil. J Med Virol. 1999;59:527–35. DOIPubMedGoogle Scholar
  8. Johnson  AM, Bowen  MD, Ksiazek  TG, Williams  RJ, Bryan  RT, Mills  JN, Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology. 1997;238:115–27. DOIPubMedGoogle Scholar
  9. Vincent  MJ, Quiroz  E, Gracia  F, Sanchez  AJ, Ksiazek  TG, Kitsutani  PT, Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. Virology. 2000;277:14–9. DOIPubMedGoogle Scholar
  10. Padula  PJ, Colavecchia  SB, Martinez  VP, Gonzalez Della Valle  MO, Edelstein  A, Miguel  SD, Genetic diversity, distribution, and serological features of hantavirus infection in five countries in South America. J Clin Microbiol. 2000;38:3029–35.PubMedGoogle Scholar
  11. Weissenbacher  MC, Cura  E, Segura  EL, Hortal  M, Baek  LJ, Chu  YK, Serological evidence of human hantavirus infection in Argentina, Bolivia and Uruguay. Medicina (B Aires). 1996;56:17–22.PubMedGoogle Scholar
  12. Nieves Parisi  MD, Enria  DA, Pini  NC, Sabattini  MS. Retrospective detection of hantavirus clinical infections in Argentina [in Spanish]. Medicina (B Aires). 1996;56:1–13.PubMedGoogle Scholar
  13. Levis  S, Morzunov  SP, Rowe  JE, Enria  D, Pini  N, Calderon  G, Genetic diversity and epidemiology of hantaviruses in Argentina. J Infect Dis. 1998;177:529–38. DOIPubMedGoogle Scholar
  14. Padula  P, Martinez  VP, Bellomo  C, Maidana  S, San Juan  J, Tagliaferri  P, Pathogenic hantaviruses, northeastern Argentina and eastern Paraguay. Emerg Infect Dis. 2007;13:1211–4.PubMedGoogle Scholar
  15. Padula  P, Della Valle  MG, Alai  MG, Cortada  P, Villagra  M, Gianella  A. Andes virus and first case report of Bermejo virus causing fatal pulmonary syndrome. Emerg Infect Dis. 2002;8:437–9. DOIPubMedGoogle Scholar
  16. Martinez  VP, Colavecchia  S, Garcia Alay  M, Suzuki  B, Trincheri  A, Busto  S, Hantavirus pulmonary syndrome in Buenos Aires Province [in Spanish]. Medicina (B Aires). 2001;61:147–56.PubMedGoogle Scholar
  17. Levis  S, Garcia  J, Pini  N, Calderon  G, Ramirez  J, Bravo  D, Hantavirus pulmonary syndrome in northwestern Argentina: circulation of Laguna Negra virus associated with Calomys callosus. Am J Trop Med Hyg. 2004;71:658–63.PubMedGoogle Scholar
  18. Burkart  R, Bárbaro  N, Sánchez  RO, Gómez  DA. Ecorregiones de la Argentina. Buenos Aires (Argentina): Administración de Parques Nacionales, Programa de Desarrollo Institucional Ambiental; 1999.
  19. Padula  PJ, Rossi  CM, Della Valle  MO, Martinez  PV, Colavecchia  SB, Edelstein  A, Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein. J Med Microbiol. 2000;49:149–55.PubMedGoogle Scholar
  20. Lazaro  ME, Resa  AJ, Barclay  CM, Calanni  L, Samengo  L, Martinez  L, Hantavirus pulmonary syndrome in southern Argentina [in Spanish]. Medicina (B Aires). 2000;60:289–301.PubMedGoogle Scholar
  21. Pinna  DM, Martinez  VP, Bellomo  CM, Lopez  C, Padula  P. New epidemiologic and molecular evidence of person to person transmission of hantavirus Andes South [in Spanish]. Medicina (B Aires). 2004;64:43–6.PubMedGoogle Scholar
  22. Campos  GM, Borges  AA, Badra  SJ, Figueiredo  GG, Souza  RL, Moreli  ML, Pulmonary and cardiovascular syndrome due to hantavirus: clinical aspects of an emerging disease in southeastern Brazil [in Portuguese]. Rev Soc Bras Med Trop. 2009;42:282–9. DOIPubMedGoogle Scholar
  23. Silva-Vergara  ML, Costa  JC Jr, Barata  CH, Curi  VG, Tiveron  CG Jr, Teixeira  AC. Hantavirus pulmonary syndrome in Uberaba, Minas Gerais, Brazil. Mem Inst Oswaldo Cruz. 2002;97:783–7. DOIPubMedGoogle Scholar
  24. Riquelme  R, Riquelme  M, Torres  A, Rioseco  ML, Vergara  JA, Scholz  L, Hantavirus pulmonary syndrome, southern Chile. Emerg Infect Dis. 2003;9:1438–43.PubMedGoogle Scholar
  25. Bellomo  C, Nudelman  J, Kwaszka  R, Vazquez  G, Cantoni  G, Weinzettel  B, Geographic expansion of hantavirus pulmonary syndrome in Argentina. The southernest case report [in Spanish]. Medicina (B Aires). 2009;69:647–50.PubMedGoogle Scholar
  26. Martinez  VP, Bellomo  C, San Juan  J, Pinna  D, Forlenza  R, Elder  M, Person-to-person transmission of Andes virus. Emerg Infect Dis. 2005;11:1848–53.PubMedGoogle Scholar
  27. Padula  PJ, Edelstein  A, Miguel  SD, Lopez  NM, Rossi  CM, Rabinovich  RD. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology. 1998;241:323–30. DOIPubMedGoogle Scholar
  28. Larrieu  E, Cantoni  G, Herrero  E, Perez  A, Talmon  G, Vazquez  G, Hantavirus antibodies in rodents and human cases with pulmonary syndrome, Rio Negro, Argentina [in Spanish]. Medicina (B Aires). 2008;68:373–9.PubMedGoogle Scholar
  29. Piudo  L, Monteverde  M, Gonzalez Capria  S, Padula  P, Carmanchahi  P. Distribution and abundance of sigmodontine rodents in relation to hantavirus in Neuquen, Argentina. J Vector Ecol. 2005;30:119–25.PubMedGoogle Scholar
  30. Delfraro  A, Clara  M, Tome  L, Achaval  F, Levis  S, Calderon  G, Yellow pigmy rice rat (Oligoryzomys flavescens) and hantavirus pulmonary syndrome in Uruguay. Emerg Infect Dis. 2003;9:846–52.PubMedGoogle Scholar
  31. Bharadwaj  M, Nofchissey  R, Goade  D, Koster  F, Hjelle  B. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis. 2000;182:43–8. DOIPubMedGoogle Scholar
  32. MacNeil  A, Comer  JA, Ksiazek  TG, Rollin  PE. Sin Nombre virus-specific immunoglobulin M and G kinetics in hantavirus pulmonary syndrome and the role played by serologic responses in predicting disease outcome. J Infect Dis. 2010;202:242–6. DOIPubMedGoogle Scholar
  33. Secretaria de Ambiente y Desarrollo Sustentable. El Convenio y nuestro país informe a las partes del convenio sobre diversidad biológica. 1998 [cited 2010 Oct 14]. http://www2.medioambiente.gov.ar/acuerdos/convenciones/cdb/dbinfa1.htm
  34. Curiel  RE, Miller  MH, Ishikawa  R, Thomas  DC, Bigley  NJ. Does the gender difference in interferon production seen in picornavirus-infected spleen cell cultures from ICR Swiss mice have any in vivo significance? J Interferon Res. 1993;13:387–95. DOIPubMedGoogle Scholar
  35. Barna  M, Komatsu  T, Bi  Z, Reiss  CS. Sex differences in susceptibility to viral infection of the central nervous system. J Neuroimmunol. 1996;67:31–9.PubMedGoogle Scholar
  36. Huber  SA, Pfaeffle  B. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J Virol. 1994;68:5126–32.PubMedGoogle Scholar
  37. Klingstrom  J, Lindgren  T, Ahlm  C. Sex-dependent differences in plasma cytokine responses to hantavirus infection. Clin Vaccine Immunol. 2008;15:885–7. DOIPubMedGoogle Scholar

Main Article

Page created: August 28, 2011
Page updated: August 28, 2011
Page reviewed: August 28, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external